Form 4: Immix Biopharma Director Reports Stock & Option Holdings

Immix Biopharma Director Nancy T. Chang reported new stock option grants and updated beneficial ownership of common stock.

Summary

• Director Nancy T. Chang reported beneficial ownership of Immix Biopharma, Inc. common stock.
• Directly owns 421,940 shares of common stock.
• Indirectly owns 496,940 shares of common stock through Robinhood II, LP, where she serves as the general manager.
• Received a grant of 39,643 stock options with an exercise price of $4.33 per share.
• The stock options were granted on November 21, 2025, and are set to expire on November 21, 2035.
• The options will vest in 36 equal monthly installments following the grant date, contingent on continued service with the Issuer.

Sentiment

Score: 6

Explanation: The filing reports a director's increased equity stake through a stock option grant, which is generally a positive signal of alignment with shareholder interests, though it's a routine compensation event and not indicative of operational performance.

Positives

• Director Nancy T. Chang received a new grant of 39,643 stock options, aligning her interests with shareholders.
• The 36-month vesting schedule for the stock options encourages long-term commitment and continued service from a key director.

Future Outlook

The stock options granted to Director Nancy T. Chang are subject to a vesting schedule over 36 equal monthly installments, contingent on her continued service with Immix Biopharma, Inc.

Industry Context

This filing is a routine disclosure of insider transactions, common across all publicly traded companies, reflecting equity compensation for directors and executives. It does not provide broader industry context.

Stakeholder Impact

• Shareholders: The grant of stock options to a director aligns her financial interests with those of the shareholders, potentially encouraging decisions that enhance long-term shareholder value.
• Employees: The vesting schedule ties the director's compensation to continued service, which can contribute to stability in leadership.

Next Steps

• Continued vesting of the 39,643 stock options in 36 equal monthly installments, subject to the reporting person's continued service.

Key Dates

Keywords

Immix Biopharma, IMMX, Nancy T. Chang, Form 4, Insider Trading, Stock Option Grant, Beneficial Ownership, Director Holdings, Equity Compensation